1. Korzets Z, Zeltzer E, Rathaus M, et al. Uremic optic neuropathy. A uremic manifestation mandating dialysis. Am J Nephrol. 1998; 18:240–2.
2. Saini JS, Jain IS, Dhar S, Mohan K. Uremic optic neuropathy. J Clin Neuroophthalmol. 1989; 9:131–3. discussion 134–5.
3. Winkelmayer WC, Eigner M, Berger O, et al. Optic neuropathy in uremia: an interdisciplinary emergency. Am J Kidney Dis. 2001; 37:E23.
Article
4. Nieto J, Zapata MA. Bilateral anterior ischemic optic neuropathy in patients on dialysis: a report of two cases. Indian J Nephrol. 2010; 20:48–50.
Article
5. Knox DL, Hanneken AM, Hollows FC, et al. Uremic optic neuropathy. Arch Ophthalmol. 1988; 106:50–4.
Article
6. Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various abdominal factors. Ophthalmology. 1987; 94:1020–8.
7. Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol. 1983; 96:478–83.
Article
8. Rucker JC, Biousse V, Newman NJ. Ischemic optic neuropathies. Curr Opin Neurol. 2004; 17:27–35.
Article
9. Ozdek S, Deren YT, Gurelik G, Hasanreisoglu B. Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser abdominal for the treatment of macular edema in branch retinal vein occlusion. Ophthalmic Res. 2008; 40:26–31.
10. Lin JM, Chiu YT, Hung PT, Tsai YY. Early treatment of severe abdominal macular edema in central retinal vein occlusion with posterior subtenon triamcinolone acetonide. Retina. 2007; 27:180–9.
11. Fesharaki H, Kianersi F, Shoyoukhi S. Therapeutic effect of abdominal subtenon methyl prednisolone in anterior ischemic optic abdominal: a randomized clinical trial. Iranian J Ophthalmol. 2011; 23:50–6.